Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.

[1]  Barney M. Berlin,et al.  Size , 1989, Encyclopedia of Evolutionary Psychological Science.

[2]  Gustavo Mercado,et al.  Uniqueness , 2021, Geochemical and Biogeochemical Reaction Modeling.

[3]  Peixuan Guo,et al.  Assessment and comparison of thermal stability of phosphorothioate-DNA, DNA, RNA, 2′-F RNA, and LNA in the context of Phi29 pRNA 3WJ , 2018, RNA.

[4]  Peixuan Guo,et al.  Hydrophobic Effect from Conjugated Chemicals or Drugs on In Vivo Biodistribution of RNA Nanoparticles. , 2018, Human gene therapy.

[5]  Peixuan Guo,et al.  Size, Shape, and Sequence-Dependent Immunogenicity of RNA Nanoparticles , 2017, Molecular therapy. Nucleic acids.

[6]  Qinfu Zhao,et al.  A comparison between sphere and rod nanoparticles regarding their in vivo biological behavior and pharmacokinetics , 2017, Scientific Reports.

[7]  Jiehua Zhou,et al.  Aptamers as targeted therapeutics: current potential and challenges , 2017, Nature Reviews Drug Discovery.

[8]  R. Zhou,et al.  Directional mechanical stability of Bacteriophage φ29 motor’s 3WJ-pRNA: Extraordinary robustness along portal axis , 2017, Science Advances.

[9]  Marilena Hadjidemetriou,et al.  Nanomedicine: Evolution of the nanoparticle corona. , 2017, Nature nanotechnology.

[10]  D. Gorenstein,et al.  RNA nanoparticles harboring annexin A2 aptamer can target ovarian cancer for tumor-specific doxorubicin delivery. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[11]  Wen Jiang,et al.  Breaking Down the Barriers to Precision Cancer Nanomedicine. , 2017, Trends in biotechnology.

[12]  Dan Peer,et al.  Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions. , 2017, ACS nano.

[13]  Peixuan Guo,et al.  Advancement of the Emerging Field of RNA Nanotechnology , 2017, ACS nano.

[14]  Samir Mitragotri,et al.  Impact of particle elasticity on particle‐based drug delivery systems☆ , 2017, Advanced drug delivery reviews.

[15]  P. Kantoff,et al.  Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.

[16]  F. Danhier,et al.  To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine? , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Emil F. Khisamutdinov,et al.  Mechanism of three-component collision to produce ultrastable pRNA three-way junction of Phi29 DNA-packaging motor by kinetic assessment , 2016, RNA.

[18]  Ian D. McGilvray,et al.  Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Emil F. Khisamutdinov,et al.  Fabrication of RNA 3D Nanoprisms for Loading and Protection of Small RNAs and Model Drugs , 2016, Advanced materials.

[20]  W. Chiu,et al.  Controllable Self‐Assembly of RNA Tetrahedrons with Precise Shape and Size for Cancer Targeting , 2016, Advanced materials.

[21]  Peixuan Guo,et al.  Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  Yuanxin Chen,et al.  Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes , 2016, Scientific Reports.

[23]  Peixuan Guo,et al.  Controllable self-assembly of RNA dendrimers. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[24]  Xing-jie Liang,et al.  RNA as a stable polymer to build controllable and defined nanostructures for material and biomedical applications , 2015, Nano today.

[25]  G. Xiong,et al.  Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology , 2015, ACS nano.

[26]  Mauro Ferrari,et al.  Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.

[27]  Peixuan Guo,et al.  Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNA , 2015, Scientific Reports.

[28]  C. Croce,et al.  RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model , 2015, Oncotarget.

[29]  S. Mitragotri,et al.  Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting. , 2015, ACS nano.

[30]  W. Mustain,et al.  Delivery of RNA nanoparticles into colorectal cancer metastases following systemic administration. , 2015, ACS nano.

[31]  Peixuan Guo,et al.  Large scale purification of RNA nanoparticles by preparative ultracentrifugation. , 2015, Methods in molecular biology.

[32]  Samir Mitragotri,et al.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies , 2014, Nature Reviews Drug Discovery.

[33]  Cody W. Geary,et al.  A single-stranded architecture for cotranscriptional folding of RNA nanostructures , 2014, Science.

[34]  Emil F. Khisamutdinov,et al.  Enhancing immunomodulation on innate immunity by shape transition among RNA triangle, square and pentagon nanovehicles , 2014, Nucleic acids research.

[35]  Daehoon Han,et al.  Self-assembly of free-standing RNA membranes , 2014, Nature Communications.

[36]  Emil F. Khisamutdinov,et al.  Physicochemically Tunable Polyfunctionalized RNA Square Architecture with Fluorogenic and Ribozymatic Properties , 2014, ACS nano.

[37]  Kevin Braeckmans,et al.  Intracellular delivery of nanomaterials: how to catch endosomal escape in the act , 2014 .

[38]  Da Ma,et al.  Enhancing endosomal escape for nanoparticle mediated siRNA delivery. , 2014, Nanoscale.

[39]  Luc Jaeger,et al.  RNA self-assembly and RNA nanotechnology. , 2014, Accounts of chemical research.

[40]  Gerhard Gompper,et al.  Margination of micro- and nano-particles in blood flow and its effect on drug delivery , 2014, Scientific Reports.

[41]  G. Church,et al.  Large-scale de novo DNA synthesis: technologies and applications , 2014, Nature Methods.

[42]  Peixuan Guo,et al.  RNA as a Boiling-Resistant Anionic Polymer Material To Build Robust Structures with Defined Shape and Stoichiometry , 2014, ACS nano.

[43]  Emil F. Khisamutdinov,et al.  Entropy-Driven One-Step Formation of Phi29 pRNA 3WJ from Three RNA Fragments , 2014, Biochemistry.

[44]  Xiue Jiang,et al.  Impact of shape and pore size of mesoporous silica nanoparticles on serum protein adsorption and RBCs hemolysis. , 2014, ACS applied materials & interfaces.

[45]  Peixuan Guo,et al.  Stable RNA nanoparticles as potential new generation drugs for cancer therapy. , 2014, Advanced drug delivery reviews.

[46]  B. Shapiro,et al.  Co-transcriptional production of RNA–DNA hybrids for simultaneous release of multiple split functionalities , 2013, Nucleic acids research.

[47]  Emil F. Khisamutdinov,et al.  Programmable folding of fusion RNA in vivo and in vitro driven by pRNA 3WJ motif of phi29 DNA packaging motor , 2013, Nucleic acids research.

[48]  Luisa M Russell,et al.  State-ofthe-Art in Design Rules for Drug Delivery Platforms : Lessons from FDA-approved Nanomedicines , 2014 .

[49]  Y. Yoshioka,et al.  The Absorption, Distribution, Metabolism, and Excretion Profile of Nanoparticles , 2014 .

[50]  V. Patravale,et al.  Endosomal escape: a bottleneck in intracellular delivery. , 2014, Journal of nanoscience and nanotechnology.

[51]  Chia-Yang Liu,et al.  Ocular Delivery of pRNA Nanoparticles: Distribution and Clearance After Subconjunctival Injection , 2014, Pharmaceutical Research.

[52]  Junya Ishikawa,et al.  RNA Tectonics (tectoRNA) for RNA nanostructure design and its application in synthetic biology , 2013, Wiley interdisciplinary reviews. RNA.

[53]  R. Jain,et al.  Strategies for advancing cancer nanomedicine. , 2013, Nature materials.

[54]  N. McGranahan,et al.  The causes and consequences of genetic heterogeneity in cancer evolution , 2013, Nature.

[55]  Peixuan Guo,et al.  Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells , 2013, Nature Protocols.

[56]  Y. Lyubchenko,et al.  Crystal structure of 3WJ core revealing divalent ion-promoted thermostability and assembly of the Phi29 hexameric motor pRNA , 2013, RNA.

[57]  Y. Lyubchenko,et al.  Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs. , 2013, RNA.

[58]  R. Jain,et al.  Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. , 2013, Cancer research.

[59]  L. Pusztai,et al.  Cancer heterogeneity: implications for targeted therapeutics , 2013, British Journal of Cancer.

[60]  Marco P Monopoli,et al.  Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.

[61]  Peixuan Guo,et al.  Fluorogenic RNA nanoparticles for monitoring RNA folding and degradation in real time in living cells. , 2012, Nucleic acid therapeutics.

[62]  Wade W Grabow,et al.  Co-transcriptional assembly of chemically modified RNA nanoparticles functionalized with siRNAs. , 2012, Nano letters.

[63]  A. Rao,et al.  Effects of surface functional groups on the formation of nanoparticle-protein corona. , 2012, Applied physics letters.

[64]  Peixuan Guo,et al.  Uniqueness, advantages, challenges, solutions, and perspectives in therapeutics applying RNA nanotechnology. , 2012, Nucleic acid therapeutics.

[65]  Fei Wu,et al.  Innentitelbild: Polyspermine Imidazole‐4,5‐imine, a Chemically Dynamic and Biologically Responsive Carrier System for Intracellular Delivery of siRNA (Angew. Chem. 32/2012) , 2012 .

[66]  Fei Wu,et al.  Polyspermine imidazole-4,5-imine, a chemically dynamic and biologically responsive carrier system for intracellular delivery of siRNA. , 2012, Angewandte Chemie.

[67]  Peixuan Guo,et al.  Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers. , 2012, Nano today.

[68]  Warren C W Chan,et al.  The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.

[69]  Daniel K. Bonner,et al.  Self-assembled RNA interference microsponges for efficient siRNA delivery. , 2012, Nature materials.

[70]  J. McNamara,et al.  Rational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modeling. , 2011, Nucleic acid therapeutics.

[71]  Gerolama Condorelli,et al.  A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death , 2011, PloS one.

[72]  Marco Mascini,et al.  Selection of thrombin-binding aptamers by using computational approach for aptasensor application. , 2011, Biosensors & bioelectronics.

[73]  Peixuan Guo,et al.  Pharmacological characterization of chemically synthesized monomeric phi29 pRNA nanoparticles for systemic delivery. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[74]  Jesse V Jokerst,et al.  Nanoparticle PEGylation for imaging and therapy. , 2011, Nanomedicine.

[75]  Sunjoo Jeong,et al.  In vitro selection of RNA aptamer and specific targeting of ErbB2 in breast cancer cells. , 2011, Nucleic acid therapeutics.

[76]  Omid C Farokhzad,et al.  Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. , 2011, Accounts of chemical research.

[77]  M. Mahmoudi,et al.  Protein-nanoparticle interactions: opportunities and challenges. , 2011, Chemical reviews.

[78]  Peixuan Guo,et al.  Thermodynamically Stable RNA three-way junctions as platform for constructing multi-functional nanoparticles for delivery of therapeutics , 2011, Nature Nanotechnology.

[79]  Dong Chen,et al.  The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. , 2011, ACS nano.

[80]  Gert Storm,et al.  Endosomal escape pathways for delivery of biologicals. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[81]  W. Duan,et al.  RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule , 2011, Cancer science.

[82]  Vladimir Torchilin,et al.  Tumor delivery of macromolecular drugs based on the EPR effect. , 2011, Advanced drug delivery reviews.

[83]  John J Rossi,et al.  Cell-specific aptamer-mediated targeted drug delivery. , 2011, Oligonucleotides.

[84]  Wade W Grabow,et al.  Self-assembling RNA nanorings based on RNAI/II inverse kissing complexes. , 2011, Nano letters (Print).

[85]  Peixuan Guo,et al.  Fabrication of stable and RNase-resistant RNA nanoparticles active in gearing the nanomotors for viral DNA packaging. , 2011, ACS nano.

[86]  Yaping Li,et al.  In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. , 2011, Small.

[87]  Conrad Steenberg,et al.  NUPACK: Analysis and design of nucleic acid systems , 2011, J. Comput. Chem..

[88]  Warren C W Chan,et al.  Strategies for the intracellular delivery of nanoparticles. , 2011, Chemical Society reviews.

[89]  Daniel A. Heller,et al.  Treating metastatic cancer with nanotechnology , 2011, Nature Reviews Cancer.

[90]  Peixuan Guo.  The emerging field of RNA nanotechnology. , 2010, Nature nanotechnology.

[91]  R. Jain,et al.  Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.

[92]  F. Dehne,et al.  Computational approaches toward the design of pools for the in vitro selection of complex aptamers. , 2010, RNA.

[93]  Eric Westhof,et al.  BIOINFORMATICS APPLICATIONS NOTE , 2022 .

[94]  Cody W. Geary,et al.  A polyhedron made of tRNAs , 2010, Nature chemistry.

[95]  D. Dykxhoorn,et al.  Breaking down the barriers: siRNA delivery and endosome escape , 2010, Journal of Cell Science.

[96]  Peixuan Guo,et al.  Engineering RNA for Targeted siRNA Delivery and Medical Application , 2010, Advanced Drug Delivery Reviews.

[97]  Bin Hu,et al.  Development of HBsAg-binding aptamers that bind HepG2.2.15 cells via HBV surface antigen , 2010, Virologica Sinica.

[98]  Xiaohong Fang,et al.  Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach. , 2010, Accounts of chemical research.

[99]  G. Stassi,et al.  The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. , 2010, Cancer research.

[100]  P. Grutter,et al.  Effect of mechanical properties of hydrogel nanoparticles on macrophage cell uptake , 2009 .

[101]  S. Beaucage,et al.  Recent Advances in the Chemical Synthesis of RNA , 2009, Current protocols in nucleic acid chemistry.

[102]  J. Rossi,et al.  RNAi-based therapeutics–current status, challenges and prospects , 2009, EMBO molecular medicine.

[103]  Michael R. Robinson,et al.  Novel Drug Delivery Systems for Retinal Diseases , 2009, Ophthalmic Research.

[104]  Cody W. Geary,et al.  Square-shaped RNA particles from different RNA folds. , 2009, Nano letters.

[105]  H. Wolfson,et al.  Analysis and classification of RNA tertiary structures. , 2008, RNA.

[106]  Thomas Lavergne,et al.  A base-labile group for 2'-OH protection of ribonucleosides: a major challenge for RNA synthesis. , 2008, Chemistry.

[107]  Bruce A Shapiro,et al.  Computational strategies for the automated design of RNA nanoscale structures from building blocks using NanoTiler. , 2008, Journal of molecular graphics & modelling.

[108]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[109]  J. Maizel,et al.  RNA2D3D: A program for Generating, Viewing, and Comparing 3-Dimensional Models of RNA , 2008, Journal of biomolecular structure & dynamics.

[110]  Kirsten L. Frieda,et al.  Direct Observation of Hierarchical Folding in Single Riboswitch Aptamers , 2008, Science.

[111]  Eckart Bindewald,et al.  RNAJunction: a database of RNA junctions and kissing loops for three-dimensional structural analysis and nanodesign , 2007, Nucleic Acids Res..

[112]  Rolf Backofen,et al.  INFO-RNA—a server for fast inverse RNA folding satisfying sequence constraints , 2007, Nucleic Acids Res..

[113]  Sailing He,et al.  Quantum rod bioconjugates as targeted probes for confocal and two-photon fluorescence imaging of cancer cells. , 2007, Nano letters.

[114]  J. Massagué,et al.  Cancer Metastasis: Building a Framework , 2006, Cell.

[115]  Arto Urtti,et al.  Challenges and obstacles of ocular pharmacokinetics and drug delivery. , 2006, Advanced drug delivery reviews.

[116]  E. Westhof,et al.  The building blocks and motifs of RNA architecture. , 2006, Current opinion in structural biology.

[117]  R. Griffey,et al.  Fully 2'-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA. , 2005, Journal of medicinal chemistry.

[118]  H. Hansma,et al.  Building Programmable Jigsaw Puzzles with RNA , 2004, Science.

[119]  C. Mao,et al.  Bottom-up Assembly of RNA Arrays and Superstructures as Potential Parts in Nanotechnology. , 2004, Nano letters.

[120]  R. Kaiser,et al.  Recent advances in the high-speed solid phase synthesis of RNA. , 2004, Current opinion in chemical biology.

[121]  L. Jaeger,et al.  TectoRNA and ‘kissing‐loop’ RNA: atomic force microscopy of self‐assembling RNA structures , 2003, Journal of microscopy.

[122]  Michael Zuker,et al.  Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..

[123]  E. Westhof,et al.  Analysis of RNA motifs. , 2003, Current opinion in structural biology.

[124]  F. Major,et al.  RNA canonical and non-canonical base pairing types: a recognition method and complete repertoire. , 2002, Nucleic acids research.

[125]  Philip S Low,et al.  Folate-mediated delivery of macromolecular anticancer therapeutic agents. , 2002, Advanced drug delivery reviews.

[126]  D. S. Coffey,et al.  Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. , 2002, Cancer research.

[127]  J. Liphardt,et al.  Reversible Unfolding of Single RNA Molecules by Mechanical Force , 2001, Science.

[128]  E. Westhof,et al.  TectoRNA: modular assembly units for the construction of RNA nano-objects. , 2001, Nucleic acids research.

[129]  Lucey Dr,et al.  Tecto-RNA: One-Dimensional Self-Assembly through Tertiary Interactions , 2000 .

[130]  H. Shinagawa,et al.  Modulation of RuvB function by the mobile domain III of the Holliday junction recognition protein RuvA. , 2000, Journal of molecular biology.

[131]  R. J. Lee,et al.  Targeted drug delivery via the folate receptor. , 2000, Advanced drug delivery reviews.

[132]  D. Patel,et al.  Adaptive recognition by nucleic acid aptamers. , 2000, Science.

[133]  D. Putnam,et al.  Design of imidazole-containing endosomolytic biopolymers for gene delivery. , 2000, Biotechnology and bioengineering.

[134]  M. Rief,et al.  Sequence-dependent mechanics of single DNA molecules , 1999, Nature Structural Biology.

[135]  S D Jayasena,et al.  Staining of cell surface human CD4 with 2'-F-pyrimidine-containing RNA aptamers for flow cytometry. , 1998, Nucleic acids research.

[136]  C. Zhang,et al.  Inter-RNA interaction of phage phi29 pRNA to form a hexameric complex for viral DNA transportation. , 1998, Molecular cell.

[137]  P. Low,et al.  Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[138]  J. Onuchic,et al.  Chemical physics of protein folding. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[139]  N. Sugimoto,et al.  Thermodynamic parameters to predict stability of RNA/DNA hybrid duplexes. , 1995, Biochemistry.

[140]  E. Lesnik,et al.  Relative thermodynamic stability of DNA, RNA, and DNA:RNA hybrid duplexes: relationship with base composition and structure. , 1995, Biochemistry.

[141]  Dudley H. Williams,et al.  On the stability of nucleic acid structures in solution: enthalpy-entropy compensations, internal rotations and reversibility. , 1993, Nucleic acids research.

[142]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.